Screening of Interactions with the ESCRT Machinery by a Gaussia princeps Split Luciferase-Based Complementation Assay.


Journal

Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969

Informations de publication

Date de publication:
2019
Historique:
entrez: 29 6 2019
pubmed: 30 6 2019
medline: 3 3 2020
Statut: ppublish

Résumé

The endosomal sorting complex required for transport (ESCRT) machinery comprises five complexes that act sequentially to recruit and cluster transmembrane cargo proteins (ESCRT-0), drive membrane curving (ESCRT-I and II), catalyze fission of cargo-containing vesicles (ESCRT-III and VPS/VTA1), and disassemble and recycle the ESCRT-III complex (VPS/VTA1). Since interactions between ESCRT components and cellular or microbial proteins are typically weak, transient, and involve membrane proteins, they are often difficult to study by standard technologies. Here, we describe the utility of high-throughput protein-fragment complementation assays based on the reconstitution of a split luciferase reporter to screen for interactions between any protein and a library of ESCRT proteins in mammalian cells and provide a detailed protocol for these assays.

Identifiants

pubmed: 31250310
doi: 10.1007/978-1-4939-9492-2_21
doi:

Substances chimiques

Endosomal Sorting Complexes Required for Transport 0
Recombinant Proteins 0
Green Fluorescent Proteins 147336-22-9
Luciferases EC 1.13.12.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

291-304

Références

Henne William M, Buchkovich Nicholas J, Emr Scott D (2011) The ESCRT pathway. Dev Cell 21(1):77–91. https://doi.org/10.1016/j.devcel.2011.05.015
doi: 10.1016/j.devcel.2011.05.015 pubmed: 21763610
Votteler J, Sundquist Wesley I (2013) Virus budding and the ESCRT pathway. Cell Host Microbe 14(3):232–241. https://doi.org/10.1016/j.chom.2013.08.012
doi: 10.1016/j.chom.2013.08.012 pubmed: 24034610
Mehra A, Zahra A, Thompson V, Sirisaengtaksin N, Wells A, Porto M, Köster S, Penberthy K, Kubota Y, Dricot A, Rogan D, Vidal M, Hill DE, Bean AJ, Philips JA (2013) Mycobacterium tuberculosis type VII secreted effector EsxH targets host ESCRT to impair trafficking. PLoS Pathog 9(10):e1003734. https://doi.org/10.1371/journal.ppat.1003734
doi: 10.1371/journal.ppat.1003734 pubmed: 24204276 pmcid: 3814348
Hirano S, Kawasaki M, Ura H, Kato R, Raiborg C, Stenmark H, Wakatsuki S (2006) Double-sided ubiquitin binding of Hrs-UIM in endosomal protein sorting. Nat Struct Mol Biol 13(3):272–277
doi: 10.1038/nsmb1051
Raiborg C, Bache KG, Gillooly DJ, Madshus IH, Stang E, Stenmark H (2002) Hrs sorts ubiquitinated proteins into clathrin-coated microdomains of early endosomes. Nat Cell Biol 4(5):394–398. http://www.nature.com/ncb/journal/v4/n5/suppinfo/ncb791_S1.html
doi: 10.1038/ncb791
Parrish J, Gulyas K, Finley R (2006) Yeast two-hybrid contributions to interactome mapping. Curr Opin Biotechnol 17(4):387–393
doi: 10.1016/j.copbio.2006.06.006
Cusick ME, Klitgord N, Vidal M, Hill DE (2005) Interactome: gateway into systems biology. Hum Mol Genet 14:R171–R181. https://doi.org/10.1093/hmg/ddi335
doi: 10.1093/hmg/ddi335 pubmed: 16162640
Garbis S, Lubec G, Fountoulakis M (2005) Limitations of current proteomics technologies. J Chromatogr A 1077(1):1–18
doi: 10.1016/j.chroma.2005.04.059
Remy I, Michnick SW (2004) A cDNA library functional screening strategy based on fluorescent protein complementation assays to identify novel components of signaling pathways. Methods 32(4):381–388
doi: 10.1016/j.ymeth.2003.10.011
Capdevila-Nortes X, López-Hernández T, Ciruela F, Estévez R (2012) A modification of the split-tobacco etch virus method for monitoring interactions between membrane proteins in mammalian cells. Anal Biochem 423(1):109–118. https://doi.org/10.1016/j.ab.2012.01.022
doi: 10.1016/j.ab.2012.01.022 pubmed: 22342621
Remy I, Michnick SW (1999) Clonal selection and in vivo quantitation of protein interactions with protein-fragment complementation assays. Proc Natl Acad Sci U S A 96(10):5394–5399
doi: 10.1073/pnas.96.10.5394
Remy I, Michnick SW (2007) Application of protein-fragment complementation assays in cell biology. BioTechniques 42(2):137–145
doi: 10.2144/000112396
Morell M, Ventura S, Avilés FX (2009) Protein complementation assays: approaches for the in vivo analysis of protein interactions. FEBS Lett 583(11):1684–1691. https://doi.org/10.1016/j.febslet.2009.03.002
doi: 10.1016/j.febslet.2009.03.002 pubmed: 19269288
Barouch-Bentov R, Neveu G, Xiao F, Beer M, Bekerman E, Schor S, Campbell J, Boonyaratanakornkit J, Lindenbach B, Lu A, Jacob Y, Einav S (2016) Hepatitis C virus proteins interact with the endosomal sorting complex required for transport (ESCRT) machinery via ubiquitination to facilitate viral envelopment. MBio 7(6). https://doi.org/10.1128/mBio.01456-16
Remy I, Michnick S (2006) A highly sensitive protein-protein interaction assay based on Gaussia luciferase. Nat Methods 3(12):977–979
doi: 10.1038/nmeth979
Cassonnet P, Rolloy C, Neveu G, Vidalain PO, Chnatier T, Pellet J, Jones L, Muller M, Demeret C, Gaud G, Vuillier F, Lotteau V, Tangy F, Favre M, Jacob Y (2011) Benchmarking a luciferase complementation assay for detecting protein complexes. Nat Methods 8(12):990–992
doi: 10.1038/nmeth.1773
Tannous BA, Kim D-E, Fernandez JL, Weissleder R, Breakefield XO (2005) Codon-optimized gaussia luciferase cDNA for mammalian gene expression in culture and in vivo. Mol Ther 11(3):435–443. https://doi.org/10.1016/j.ymthe.2004.10.016
doi: 10.1016/j.ymthe.2004.10.016 pubmed: 15727940
Neveu G, Barouch-Bentov R, Ziv-Av A, Gerber D, Jacob Y, Einav S (2012) Identification and targeting of an interaction between a tyrosine motif within hepatitis C virus core protein and AP2M1 essential for viral assembly. PLoS Pathog 8(8):e1002845
doi: 10.1371/journal.ppat.1002845
Rual JF, Hirozane Kishikawa T, Hao T, Bertin N, Li S, Dricot A, Li N, Rosenberg J, Lamesch P, Vidalain PO, Clingingsmith T, Hartley J, Esposito D, Cheo D, Moore T, Simmons B, Sequerra R, Bosak S, Doucette-Stamm L, Le Peuch C, Vandenhaute J, Cusick M, Albala J, Hill D, Vidal M (2004) Human ORFeome version 1.1: a platform for reverse proteomics. Genome Res 14(10B):2128–2135
doi: 10.1101/gr.2973604
Neveu G, Cassonnet P, Vidalain P-O, Rolloy C, Mendoza J, Jones L, Tangy F, Muller M, Demeret C, Tafforeau L, Lotteau V, Rabourdin Combe C, Travé G, Al D, Hill D, Vidal M, Favre M, Jacob Y (2012) Comparative analysis of virus-host interactomes with a mammalian high-throughput protein complementation assay based on Gaussia princeps luciferase. Methods 58(4):349–359
doi: 10.1016/j.ymeth.2012.07.029
Hill SJ, Rolland T, Adelmant G, Xia X, Owen MS, Dricot A, Zack TI, Sahni N, Jacob Y, Hao T, McKinney KM, Clark AP, Reyon D, Tsai SQ, Joung JK, Beroukhim R, Marto JA, Vidal M, Gaudet S, Hill DE, Livingston DM (2014) Systematic screening reveals a role for BRCA1 in the response to transcription-associated DNA damage. Genes Dev 28(17):1957–1975. https://doi.org/10.1101/gad.241620.114
doi: 10.1101/gad.241620.114 pubmed: 25184681 pmcid: 4197947
Sahni N, Yi S, Taipale M, Fuxman Bass JI, Coulombe-Huntington J, Yang F, Peng J, Weile J, Karras GI, Wang Y, Kovács IA, Kamburov A, Krykbaeva I, Lam MH, Tucker G, Khurana V, Sharma A, Liu Y-Y, Yachie N, Zhong Q, Shen Y, Palagi A, San-Miguel A, Fan C, Balcha D, Dricot A, Jordan DM, Walsh JM, Shah AA, Yang X, Stoyanova A, Leighton A, Calderwood MA, Jacob Y, Cusick ME, Salehi-Ashtiani K, Whitesell LJ, Sunyaev S, Berger B, Barabási A-L, Charloteaux B, Hill DE, Hao T, Roth FP, Xia Y, Walhout AJM, Lindquist S, Vidal M (2015) Widespread macromolecular interaction perturbations in human genetic disorders. Cell 161(3):647–660. https://doi.org/10.1016/j.cell.2015.04.013
doi: 10.1016/j.cell.2015.04.013 pubmed: 25910212 pmcid: 4441215

Auteurs

Rina Barouch-Bentov (R)

Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.

Yves Jacob (Y)

Département de Virologie, Unité de Génétique Moléculaire des Virus ARN (GMVR), Institut Pasteur, Centre national de la recherche scientifique, Université Paris Diderot, Paris, France.

Shirit Einav (S)

Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA. seinav@stanford.edu.
Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA. seinav@stanford.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH